Insulet (NSDQ:PODD) said today it inked a 5-year deal with ATS Automation Tooling Systems to construct an automated manufacturing assembly line for its products and announced a pair of new executive appointments.
Billerica, Mass.-based Insulet said it expects the contract with ATS to cost approximately $35 million. ATS is slated to design, build and install manufacturing equipment developed according to technical specifications provided by Insulet, according to an SEC filing.
The company also said it tapped Dr. Trang Ly as its new veep and medical director, effective Sept. 12, and picked former Abbott (NYSE:ABT) Diabetes Care biz dev and alliance management director Brittany Bradrick as its new veep of strategy and corporate development, effective Sept. 2.
“We are very pleased to welcome Trang and Brittany to our executive team. Trang is one of the nation’s leading experts in artificial pancreas research and development with years of clinical experience in endocrinology and diabetes in the United States and Australia. Her proven expertise will be a significant asset as we continue to advance our artificial pancreas program and broaden our product development agenda. Brittany brings deep industry knowledge and an exceptional skillset to our leadership team. She will partner with our management team to help Insulet advance our strategic roadmap and maximize the full potential of our external partnerships,” CEO Patrick Sullivan said in a press release.
